Insulet Corporation (PODD): Price and Financial Metrics


Insulet Corporation (PODD): $282.45

0.85 (+0.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PODD POWR Grades


  • PODD scores best on the Quality dimension, with a Quality rank ahead of 62.31% of US stocks.
  • PODD's strongest trending metric is Quality; it's been moving down over the last 31 weeks.
  • PODD ranks lowest in Sentiment; there it ranks in the 12th percentile.

PODD Stock Summary

  • With a one year PEG ratio of 5,854.33, Insulet Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 99.2% of US stocks.
  • PODD's current price/earnings ratio is 2,032.29, which is higher than 99.65% of US stocks with positive earnings.
  • The price/operating cash flow metric for Insulet Corp is higher than 98.9% of stocks in our set with a positive cash flow.
  • Stocks that are quantitatively similar to PODD, based on their financial statements, market capitalization, and price volatility, are NVCR, GOOD, VSAT, MMSI, and AMRN.
  • PODD's SEC filings can be seen here. And to visit Insulet Corp's official web site, go to www.insulet.com.

PODD Price Target

For more insight on analysts targets of PODD, see our PODD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $283.12 Average Broker Recommendation 1.6 (Moderate Buy)

PODD Stock Price Chart Interactive Chart >

Price chart for PODD

PODD Price/Volume Stats

Current price $282.45 52-week high $306.46
Prev. close $281.60 52-week low $175.35
Day low $279.00 Volume 518,800
Day high $282.61 Avg. volume 523,141
50-day MA $269.55 Dividend yield N/A
200-day MA $255.97 Market Cap 18.72B

Insulet Corporation (PODD) Company Bio


Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company was founded in 2000 and is based in Billerica, Massachusetts.


PODD Latest News Stream


Event/Time News Detail
Loading, please wait...

PODD Latest Social Stream


Loading social stream, please wait...

View Full PODD Social Stream

Latest PODD News From Around the Web

Below are the latest news stories about Insulet Corp that investors may wish to consider to help them evaluate PODD as an investment opportunity.

Was The Smart Money Right About Insulet Corporation (PODD)?

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]

Yahoo | May 10, 2021

Insulet to Present at BofA Securities 2021 Virtual Healthcare Conference

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the virtual BofA Securities 2021 Health Care Conference on Wednesday, May 12, 2021 at 4:15 p.m. (Eastern Time).

Yahoo | May 4, 2021

Insulet 2020 Sustainability Report Conveys Strategy to Deliver Growth with Purpose

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the publication of its 2020 Sustainability Report. The report, which includes Insulet’s first comprehensive sustainability strategy and materiality assessment, highlights the Company’s areas of focus and performance on Environmental, Social, and Governance (ESG) issues.

Yahoo | May 3, 2021

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ: AXNX ) Boston Scientific Corporation (NYSE: BSX ) (reacted to first-quarter results) Celcuity Inc. (NASDAQ: CELC ) Celldex Therapeutics, Inc. (NASDAQ: CLDX) Galectin Therapeutics Inc. (NASDAQ: GALT ) Horizon Therapeutics Public Limited Company (NASDAQ: HZNP ) Insulet Corporation (NASDAQ: PODD ) Integra LifeSciences Holdings Corporation (NASDAQ: IART ) (announced first-quarter results) Lantheus Holdings, Inc. (NASDAQ: LNTH ) MacroGenics, Inc. (NASDAQ: MGNX ) NuVasive, Inc. (NASDAQ: NUVA) PRA Health Sciences, Inc. (NASDAQ: PRAH ) ShockWave Medical, Inc. (NASDAQ: SWAV ) Verastem, Inc. (NASDAQ: VSTM ) Down In The Dumps (Bi...

Benzinga | April 29, 2021

Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021

Q1'21 Earnings Release Schedule

Yahoo | April 5, 2021

Read More 'PODD' Stories Here

PODD Price Returns

1-mo 21.53%
3-mo 4.79%
6-mo 16.83%
1-year 56.43%
3-year 185.02%
5-year 834.34%
YTD 10.49%
2020 49.32%
2019 115.83%
2018 14.96%
2017 83.12%
2016 -0.34%

Continue Researching PODD

Here are a few links from around the web to help you further your research on Insulet Corp's stock as an investment opportunity:

Insulet Corp (PODD) Stock Price | Nasdaq
Insulet Corp (PODD) Stock Quote, History and News - Yahoo Finance
Insulet Corp (PODD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8189 seconds.